Skip to main content
. Author manuscript; available in PMC: 2011 Apr 26.
Published in final edited form as: Vaccine. 2010 Mar 4;28(19):3333–3340. doi: 10.1016/j.vaccine.2010.02.089

Figure 1.

Figure 1

Survival curves for the Open Trial (Study #1) consisting of Control (untreated) dogs, or dogs treated with either the Leish-111f + MPL-SE Vaccine alone, Glucantime alone, or Vaccine + Glucantime. Dogs were monitored monthly for the first 6 months and then yearly. Percent survival of dogs in each group is shown. Dogs removed from the study because of non-compliance with the protocol (i.e., left the area or ran away from owner) are censored in this graph. *All the seven surviving dogs in the saline group remained clinically sick at six months. These dogs were withdrawn from the study and from survival monitoring according to the study protocol.